Compare ARK Genomic Revolution ETF (ARKG) vs iShares JPMorgan USD Emerging Markets Bond ETF (EMB) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs iShares JPMorgan USD Emerging Markets Bond ETF — how do they compare? ARK Genomic Revolution ETF trades at $40.95, while iShares JPMorgan USD Emerging Markets Bond ETF trades at $96. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, iShares JPMorgan USD Emerging Markets Bond ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | EMB | |
|---|---|---|
Sector | Sector/Thematic | Fixed Income |
52-Week High | $43.57 | $97.74 |
52-Week Low | $23.09 | $91.52 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
EMB trades at $95.99, showing minimal daily movement with a 0.03% gain. Technical indicators signal a bearish trend, while oscillators remain neutral. Recent corporate actions include scheduled dividend payments for mid-2026. News coverage highlights emerging market bond risks and Federal Reserve policy impacts on performance.
The outlook for EMB is cautious due to emerging market sovereign default risks and interest rate sensitivity. Investment opportunity lies in its yield for income-focused investors, but macroeconomic volatility and geopolitical tensions present significant headwinds for sustained appreciation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About iShares JPMorgan USD Emerging Markets Bond ETF
EMB invests in U.S. dollar-denominated sovereign debt from emerging market countries. It provides exposure to government bonds from dozens of nations like Turkey, Mexico, and Brazil, offering a way to seek higher yields and geographic diversification.
Read more on EMB →
